Nanologica leverages its carrier materials to play a key part in the four-year EU project, ORCHID. Led by GlaxoSmithKline (GSK), the project aims to discover and develop new medicines against multiple drug resistant tuberculosis.
Vorbeck, in partnership with the Pacific Northwest National Labs (PNNL) and Princeton University, is leading the effort to commercialize next generation lithium batteries incorporating graphene technology.
mPhase Technologies, Inc. said today that it has been developing intellectual property based on an innovative platform technology to control the flow of fluids by electronically manipulating the way liquids behave when in contact with a solid or porous surface.
Tegal Corporation today announced renewed efforts to make available the balance of its semiconductor process-related intellectual property portfolio. The remaining portfolio consists of thin film structures and process technology pertaining to copper barrier and low-k dielectric technology.
Konica Minolta IJ Technologies, Inc. announced today that the company developed KM128SNG-MB, a high precision inkjet printhead, with the first use of MEMS technology at Konica Minolta. KM128SNG-MB delivers tiny drop size (1 picoliter) for the first time for printed electronics applications.
The article, entitled Carbon Nanotubes: Solution for the Therapeutic Delivery of siRNA? highlights the use of carbon nanotubes for therapeutic applications and reports on the recent advances of Ensysce as it moves its technology toward IND enabling studies and a Phase 1 clinical trial.
Proceeds from the offering will be used for working capital and research and development related to Arrogene's diagnostic and therapeutic technologies for brain, breast and lung cancer. WestPark Capital acted as placement agent for the offering.
Brion Technologies, a division of ASML, today announces a new product for semiconductor manufacturers who need the most powerful computational lithography for the next node of chip manufacturing, for a new generation of faster and more energy-efficient electronic devices.
The aim of the internationalization award is to promote company activities in an international environment and their ability to develop and implement new operating models. It is also intended to encourage the winning companies' internationalization and that of other Finnish companies.
ASELTA Nanographics develops software solutions that reduce manufacturing writing time costs for chips at the 32nm node and beyond while improving pattern fidelity, including cycle time and lithography-image quality.
Founded by veterans of Argonne National Lab, NCBI, Integrated Genomics and Ariadne, the company is taking on the challenge of functional annotation of the next-generation sequencing projects for the life science community.